Jury awards $1.5M in Prempro damages to P.R. woman

Pfizer must pay $1.5 million in damages to a pharmacist who developed breast cancer after taking one of the company's menopause drugs, a jury in Puerto Rico ruled. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.